TOLER8

Welcome to the Brand page for “TOLER8”, which is offered here for In the statement, column 1 line 6 haemopbilia should be deleted and haemophilia should be inserted.;pharmaceutical preparations and substances for the treatment of [haemopbilia] * haemophilia * and/or von willebrand disease; blood products and products derived from blood and/or recombinant dna technology, blood clotting factors; pharmaceutical preparations in the nature of factor viii blood preparations for the treatment of excessive bleeding; immunoglobulins;tolerate;.

Its status is currently believed to be active. Its class is unavailable. “TOLER8” is believed to be currently owned by “CSL Limited”.


Owner:
CSL LIMITED
Owner Details
Description:
In the statement, Column 1 line 6 haemopbilia should be deleted and haemophilia should be inserted.;Pharmaceutical preparations and substances for the treatment of [haemopbilia] * haemophilia * and/or Von Willebrand disease; blood products and products derived from blood and/or recombinant DNA technology, blood clotting factors; pharmaceutical preparations in the nature of factor VIII blood preparations for the treatment of excessive bleeding; immunoglobulins;TOLERATE;
Categories: STATEMENT